Search News Archives
Conferences | Events
Sphere Fluidics Appoints Dr Tris Vaughan as Scientific Advisor
Sphere Fluidics, a company providing single cell analysis systems underpinned by its patented picodroplet technology, has announced that Tris Vaughan, PhD FRSB has joined its scientific advisory board (SAB).
Dr Vaughan’s appointment will further strengthen the company’s understanding of biopharmaceutical discovery and cell line development and help translate its technology to an industrial context.
Dr Frank Craig, CEO, Sphere Fluidics, said: “Dr Vaughan’s knowledge and expertise gained throughout his longstanding and successful career in biopharmaceutical discovery and development will be an invaluable addition to our board of scientific advisors. We look forward to working with him to help strengthen the application of our technology for the industry.”
Dr Tris Vaughan, Scientific Advisory Board Member, Sphere Fluidics, said: “I am delighted to have been invited to join the SAB for Sphere Fluidics. I look forward to offering my input as the company works to advance microfluidic picodroplet technology and improve upon biotherapeutic discovery and development. It will be my pleasure to collaborate with the Sphere Fluidics team and offer scientific direction to the organization.”